Agreement - February 8, 2017
Bactiguard and Smartwise in license agreement
Bactiguard and Smartwise Sweden have entered into a joint development project for advanced, Bactiguard-coated vascular injection catheters and at the same time, a license agreement has been signed. Under the agreement, Smartwise will pay USD 2.5 million, for the exclusive and global right to the Bactiguard technology for this application, payable in 2017, and followed by […]
Agreement - February 6, 2017
OssDsign announces new agreement
OssDsign has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market. OssDsign recently announced FDA 510(k) clearance of OSSDSIGN Cranial PSI, a patient-specific medical implant intended for reconstruction of cranial defects. Matador Medical was founded and is led by Paul Byerley, who was previously senior vice president […]
Agreement - February 1, 2017
InDex Pharmaceuticals enters agreement
InDex Pharmaceuticals Holding has entered an agreement for services with the global contract research organization (CRO) PAREXEL for the implementation of the CONDUCT study. The CONDUCT is a phase IIb dose optimisation study with the drug candidate cobitolimod for the treatment of moderate to severe active ulcerative colitis. According to the agreement, the first patient […]
Agreement - January 31, 2017
Novo Nordisk invests in new research center
University of Oxford and Novo Nordisk announces a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on […]
Agreement - January 31, 2017
DermoScan and SciBase sign agreement
SciBase has signed an agreement with the German medical device company DermoScan to link Nevisense with its EIS measurement for early detection of malignant melanoma, with DermoScan’s digital dermoscopy system DermoGenius Ultra. DermoScan is one of Europe’s foremost manufacturers of digital dermoscopy systems. The agreement means that EIS measurements from Nevisense will be integrated as […]
Agreement - January 24, 2017
NeuroVive in new research agreement
NeuroVive Pharmaceutical has signed a preclinical collaboration agreement with the Children’s Hospital of Philadelphia (CHOP) and Marni J. Falk, M.D., a US opinion leader in the mitochondrial medicine field. Dr. Falk’s research team at CHOP will evaluate compounds from NeuroVive’s research program, NVP015, in certain experimental disease models. The research team will study energy metabolism […]
